Understanding Deep Vein Thrombosis and Blood Clots in Young Athletes
When professional football player Jalen Hurts was diagnosed with deep vein thrombosis and blood clots in both lungs, it brought rare medical events in young athletes into the public eye. While vascular conditions like blood clots are more frequently diagnosed in older adults, medical experts emphasize that acute risk factors, such as physical injuries, can create vulnerabilities in younger individuals as well.
How Injuries Trigger Vascular Risks
Physical trauma can instigate an inflammatory process within the body, which subsequently elevates the risk of developing abnormal blood clotting. According to Dr. Gita Lisker, a pulmonologist at Northwell’s Long Island Jewish Medical Center, an initial injury can act as a catalyst. In the case of professional athletes, contact injuries or localized trauma may pave the way for more severe vascular complications.
Medical professionals explain that clotting issues can sometimes begin as superficial vein thrombosis, a condition where clots form in veins directly beneath the skin. This typically causes local inflammation, redness, and swelling. However, these superficial clots can potentially progress into deep vein thrombosis, or DVT, where clots develop deeper inside the vascular system, most commonly in the legs.
Recognizing Symptoms and Complications
Deep vein thrombosis carries the significant risk of a clot breaking loose and traveling to the lungs, resulting in a pulmonary embolism. While not every DVT leads to a pulmonary embolism, the vast majority of pulmonary embolisms originate from deep vein clots in the extremities. Patients experiencing DVT may notice swelling, pain, and redness in a single leg.
Conversely, the warning signs of a pulmonary embolism involve respiratory and cardiovascular symptoms, including:
- Sudden shortness of breath
- Unexplained chest pain
- Palpitations or a racing heartbeat
- Lightheadedness or dizziness
Experts note that identifying these manifestations promptly is critical for preventing life-threatening outcomes.
Standard Treatment and Recovery Guidelines
Anticoagulation therapy, commonly known as blood thinners, serves as the standard medical approach for managing both deep vein thrombosis and pulmonary embolisms. The primary objectives of this treatment are to stop new clots from forming and to stabilize existing blockages while the body’s natural processes reabsorb them. Anticoagulation typically continues for a duration of three to six months, depending on an individual’s specific risk profile.
Because blood thinners increase the likelihood of bleeding, patients undergoing this treatment are advised to steer clear of high-impact contact sports and activities that carry a high risk of trauma or cuts. At the same time, maintaining a safe level of physical activity is considered essential. Dr. Bushra Mina, chief of pulmonary medicine at Northwell’s Northern Westchester Hospital, points out that staying appropriately active during recovery helps prevent lingering respiratory and conditioning challenges once the treatment period concludes. Medical teams generally evaluate each patient individually to tailor recovery plans safely.
